Administration Finalizes Medicare Drug Pricing Rules
On Nov. 20, 2020, the U.S. Department of Health and Human Services (HHS) issued two new drug pricing rules. The HHS Office of Inspector General released a prepublication version of a final rule that bans drug rebates in Medicare Part D that are not passed on to patients at the point of sale. Additionally, the Centers for Medicare & Medicaid Services released a prepublication version of an interim final rule to lower what Medicare Part B pays for certain drugs to what other countries pay by establishing a mandatory nationwide demonstration to test a new “most favored nation” payment model.
